X
11Nov

COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)

Hogan Lovells | | Return|
In Tuesday's Report: the expanding role of real-world evidence in FDA medical device submissions; President-elect Joe Biden lays out COVID-19 plan; Pfizer announces vaccine efficacy; and an analysis of material adverse change (MAC) clauses in Japan....
By: Hogan Lovells
Source Url: https://www.jdsupra.com/legalnews/covid-19-report-for-life-sciences-and-24214/

Related

California Court Keeps AB 51 on Hold

The Chamber of Commerce and employer organizations convinced a federal court judge in California to ...

Read More >

South Carolina Department of Revenue Announces Changes to County Tiers for 2020

The South Carolina Department of Revenue has released the 2020 county tier rankings for all South Ca...

Read More >

Quarterly Corporate / M&A Decisions Update| Q2 2019

This update is designed to highlight selected important M&A, corporate and commercial court decision...

Read More >

NLRB Limits Duty to Bargain Over Disciplinary Actions

A unionized employer must bargain with its employees’ union before making any unilateral changes in...

Read More >

New Jersey Department of Labor Releases Final Regulations for Earned Sick Leave Law

On January 6, 2020, the New Jersey Department of Labor and Workforce Development (the “Department”...

Read More >

California Supreme Court: Time Spent During Exit Searches is Compensable

The California Supreme Court has handed down yet another decision broadening the scope of what is co...

Read More >